BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $866,000 | -88.8% | 10,667 | -88.5% | 0.02% | -84.1% |
Q4 2019 | $7,726,000 | +1860.9% | 92,404 | +1950.7% | 0.11% | +2040.0% |
Q3 2019 | $394,000 | -99.4% | 4,506 | -99.4% | 0.01% | -99.2% |
Q2 2019 | $63,894,000 | -54.9% | 780,156 | -55.3% | 0.65% | -50.2% |
Q1 2019 | $141,792,000 | -39.1% | 1,743,856 | -50.7% | 1.31% | -36.6% |
Q4 2018 | $232,811,000 | -15.6% | 3,537,086 | -1.1% | 2.06% | +9.6% |
Q3 2018 | $275,771,000 | +2.6% | 3,577,272 | -1.8% | 1.88% | -1.7% |
Q2 2018 | $268,870,000 | +18.0% | 3,641,253 | +4.0% | 1.92% | +5.5% |
Q1 2018 | $227,803,000 | +13.7% | 3,502,519 | +13.0% | 1.82% | -1.7% |
Q4 2017 | $200,279,000 | +21.6% | 3,098,384 | +18.1% | 1.85% | +7.3% |
Q3 2017 | $164,647,000 | +2.1% | 2,623,864 | -1.5% | 1.72% | -11.9% |
Q2 2017 | $161,224,000 | +16.6% | 2,663,106 | -0.1% | 1.95% | +0.1% |
Q1 2017 | $138,245,000 | +18.6% | 2,665,751 | +1.4% | 1.95% | -2.8% |
Q4 2016 | $116,582,000 | -4.2% | 2,629,278 | +2.9% | 2.01% | -4.7% |
Q3 2016 | $121,675,000 | +7.1% | 2,556,204 | +1.8% | 2.11% | -0.8% |
Q2 2016 | $113,562,000 | +661.5% | 2,511,337 | +591.8% | 2.13% | +597.7% |
Q1 2016 | $14,912,000 | +2042.5% | 363,010 | +1612.3% | 0.30% | +1425.0% |
Q3 2015 | $696,000 | -71.8% | 21,200 | -38.4% | 0.02% | -83.6% |
Q3 2014 | $2,468,000 | +1.3% | 34,400 | +2.1% | 0.12% | -10.9% |
Q2 2014 | $2,436,000 | -44.3% | 33,700 | -49.4% | 0.14% | -67.1% |
Q3 2013 | $4,374,000 | +51.1% | 66,600 | +59.3% | 0.42% | +19.5% |
Q2 2013 | $2,895,000 | – | 41,800 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
Third Point | 4,000,000 | $344,400,000 | 4.72% |
Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |